The global genomics market size was estimated at USD 21.76 billion in 2025 and is projected to reach USD 72.50 billion by 2033, growing at a CAGR of 18.2% from 2026 to 2033. The market is experiencing rapid expansion due to increasing adoption of genomics technologies across healthcare, biotechnology, pharmaceuticals, and life science research applications. The growth is strongly...

The global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...

Integration of Biometric Feedback in Motorized Wheelchair Systems The landscape of assistive mobility technology is undergoing a radical shift as we enter 2026. One of the most significant developments is the embedding of high-fidelity biometric sensors within the seating and control interfaces of motorized wheelchair systems. These sensors allow for real-time monitoring of heart rate, oxygen...

Clinical genetic testing adoption across China's extensive hospital network is approaching what many industry observers characterize as an inflection point in 2026, as oncology genomic profiling, reproductive genetic testing, rare disease genetic diagnosis, and pharmacogenomic testing transition from specialized academic medical center services to mainstream clinical tools deployed across...

The Clinical Genomics Market is undergoing a transformative phase as advancements in genomic sequencing technologies continue to reshape the healthcare landscape. Precision medicine is at the forefront, leveraging genomic data to tailor therapies specifically to individual patients, which significantly enhances treatment efficacy and reduces adverse effects. Key drivers include the rising...

The North America Colorectal Cancer Market holds a dominant position globally due to the region's well-established healthcare systems, high healthcare expenditure, and growing focus on cancer prevention and management. Countries such as the United States and Canada are witnessing increased adoption of advanced diagnostic techniques and innovative therapeutic approaches, including immunotherapy...